• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文会议>International Conference on Education Science and Economic Management >Efficiency Evaluation of Chinese Patent Medicine Listed Companies in China - A Stock Market Based on DEA Model
【24h】

Efficiency Evaluation of Chinese Patent Medicine Listed Companies in China - A Stock Market Based on DEA Model

机译：中国专利医学在中国上市公司的效率评价 - 基于DEA模型的股票市场

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In order to improve the level of business decision-making and promote the development of Chinese patent medicine companies, this paper selects 8 indicators in the financial statements of 23 related listed companies in China A stock market in 2016 as examples. By constructing the Chinese patent medicine performance efficiency index system, our research chooses to use DEA model to estimate the comprehensive technical efficiency, pure technical efficiency, scale efficiency and scale efficiency characteristics. The results show that the overall efficiency of Chinese patent medicine listed companies is at a medium high level and the input-output ratio is generally higher. However, most companies have different degrees of DEA ineffective which have relatively stable scale efficiency and poor pure technical efficiency. We report here that the corporate managers should optimize the allocation of enterprise resources and increase investment in R&D and innovation to promote the improvement of corporate economies of scale and profit growth on the basis of maintaining the current level of fiscal management.
机译：为了提高商业决策和促进中国专利医学公司的发展，本文选择了2016年中国股市23个相关上市公司的财务报表中的8个指标。通过构建中国专利医学的性能效率指标体系，我们的研究选择使用DEA模型来估算综合技术效率，纯粹的技术效率，规模效率和规模效率的特点。结果表明，中国专利医学的整体效率上市公司处于中等高位，投入产出率一般较高。然而，大多数公司具有不同程度的DEA无效，具有相对稳定的规模效率和劣质技术效率。我们在此报告，公司经理应优化企业资源的配置，增加研发和创新的投资，促进在维持现行财政管理水平的基础上提高企业规模和利润增长的提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号